Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Buchner

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Advanced Materials (Deerfield Beach, Fla.)|February 23, 2022
Microfluidic Tissue Engineering and Bio-ActuationMiriam Filippi, Thomas Buchner, Oncay Yasa, et al.
Arthritis and Rheumatism|February 28, 2009
Clinical image: Lupus erythematosus cells in ascites fluidUtz Krug, Thomas Buchner, Till Fassbinder, et al.
Nature|September 4, 2020
Sub-cycle atomic-scale forces coherently control a single-molecule switchDominik Peller, Lukas Z Kastner, Thomas Buchner, et al.
Science Advances|January 5, 2024
Low-voltage electrohydraulic actuators for untethered roboticsStephan-Daniel Gravert, Elia Varini, Amirhossein Kazemipour, et al.
Haematologica|September 8, 2006
Expression of angiopoietins and their receptor Tie2 in the bone marrow of patients with acute myeloid leukemiaChristoph Schliemann, Ralf Bieker, Teresa Padro, et al.
Blood|October 24, 2002
Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 TrialWolfgang Kern, Torsten Haferlach, Claudia Schoch, et al.
British Journal of Haematology|November 25, 2015
A 4-gene expression score associated with high levels of Wilms Tumor-1 (WT1) expression is an adverse prognostic factor in acute myeloid leukaemiaAhmadreza Niavarani, Tobias Herold, Yasmin Reyal, et al.
Blood|July 16, 2005
Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemiaMatthias Stelljes, Martin Bornhauser, Matthias Kroger, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Advanced Materials (Deerfield Beach, Fla.)|February 23, 2022
Microfluidic Tissue Engineering and Bio-ActuationMiriam Filippi, Thomas Buchner, Oncay Yasa, et al.
Arthritis and Rheumatism|February 28, 2009
Clinical image: Lupus erythematosus cells in ascites fluidUtz Krug, Thomas Buchner, Till Fassbinder, et al.
Nature|September 4, 2020
Sub-cycle atomic-scale forces coherently control a single-molecule switchDominik Peller, Lukas Z Kastner, Thomas Buchner, et al.
Science Advances|January 5, 2024
Low-voltage electrohydraulic actuators for untethered roboticsStephan-Daniel Gravert, Elia Varini, Amirhossein Kazemipour, et al.
Haematologica|September 8, 2006
Expression of angiopoietins and their receptor Tie2 in the bone marrow of patients with acute myeloid leukemiaChristoph Schliemann, Ralf Bieker, Teresa Padro, et al.
Blood|October 24, 2002
Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 TrialWolfgang Kern, Torsten Haferlach, Claudia Schoch, et al.
British Journal of Haematology|November 25, 2015
A 4-gene expression score associated with high levels of Wilms Tumor-1 (WT1) expression is an adverse prognostic factor in acute myeloid leukaemiaAhmadreza Niavarani, Tobias Herold, Yasmin Reyal, et al.
Blood|July 16, 2005
Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemiaMatthias Stelljes, Martin Bornhauser, Matthias Kroger, et al.
Pageof 1